These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 23379537)

  • 21. Efficacy and safety of oral budesonide suspension in pediatric patients with eosinophilic esophagitis.
    Gupta SK; Vitanza JM; Collins MH
    Clin Gastroenterol Hepatol; 2015 Jan; 13(1):66-76.e3. PubMed ID: 24907502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostaglandin H2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2.
    Schuligoi R; Sedej M; Waldhoer M; Vukoja A; Sturm EM; Lippe IT; Peskar BA; Heinemann A
    J Leukoc Biol; 2009 Jan; 85(1):136-45. PubMed ID: 18835884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of an Oral CRTh2 Antagonist (AZD1981) on Eosinophil Activity and Symptoms in Chronic Spontaneous Urticaria.
    Oliver ET; Chichester K; Devine K; Sterba PM; Wegner C; Vonakis BM; Saini SS
    Int Arch Allergy Immunol; 2019; 179(1):21-30. PubMed ID: 30879003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children.
    Rubinstein E; Lee JJ; Fried A; Logvinenko T; Ngo P; McDonald D; Hait EJ
    J Pediatr Gastroenterol Nutr; 2014 Sep; 59(3):317-20. PubMed ID: 24821535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and Efficacy of Budesonide Oral Suspension Maintenance Therapy in Patients With Eosinophilic Esophagitis.
    Dellon ES; Katzka DA; Collins MH; Gupta SK; Lan L; Williams J; Hirano I
    Clin Gastroenterol Hepatol; 2019 Mar; 17(4):666-673.e8. PubMed ID: 29902649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia.
    Sridhara S; Ravi K; Smyrk TC; Kita H; Kephart GM; Weiler CR; Katzka DA
    Clin Gastroenterol Hepatol; 2012 Jul; 10(7):735-41. PubMed ID: 22289868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized study of BI 671800, a CRTH2 antagonist, as add-on therapy in poorly controlled asthma.
    Miller D; Wood C; Bateman E; LaForce C; Blatchford J; Hilbert J; Gupta A; Fowler A
    Allergy Asthma Proc; 2017 Mar; 38(2):157-164. PubMed ID: 28234053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of antigen-induced airway inflammation and hyperresponsiveness in guinea pigs by a selective antagonist of "chemoattractant receptor homologous molecule expressed on Th2 cells" (CRTH2).
    Tasaki M; Kobayashi M; Tenda Y; Tsujimoto S; Nakazato S; Numazaki M; Hirano Y; Matsuda H; Terasaka T; Miyao Y; Shimizu Y; Hirayama Y
    Eur J Pharm Sci; 2013 Jun; 49(3):434-40. PubMed ID: 23624353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.
    van Rhijn BD; Weijenborg PW; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1815-23.e2. PubMed ID: 24657840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
    Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
    Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy.
    Sykes DA; Bradley ME; Riddy DM; Willard E; Reilly J; Miah A; Bauer C; Watson SJ; Sandham DA; Dubois G; Charlton SJ
    Mol Pharmacol; 2016 May; 89(5):593-605. PubMed ID: 26916831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammation.
    Uller L; Mathiesen JM; Alenmyr L; Korsgren M; Ulven T; Högberg T; Andersson G; Persson CG; Kostenis E
    Respir Res; 2007 Feb; 8(1):16. PubMed ID: 17328802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal Evaluation of Noninvasive Biomarkers for Eosinophilic Esophagitis.
    Min SB; Nylund CM; Baker TP; Ally M; Reinhardt B; Chen YJ; Nazareno L; Moawad FJ
    J Clin Gastroenterol; 2017 Feb; 51(2):127-135. PubMed ID: 27479142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRTH2 mediates the activation of human Th2 cells in response to PGD(2) released from IgE/anti-IgE treated nasal polyp tissue.
    Pérez-Novo CA; Holtappels G; Vinall SL; Xue L; Zhang N; Bachert C; Pettipher R
    Allergy; 2010 Mar; 65(3):304-10. PubMed ID: 19839971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.
    Hirano I; Dellon ES; Hamilton JD; Collins MH; Peterson K; Chehade M; Schoepfer AM; Safroneeva E; Rothenberg ME; Falk GW; Assouline-Dayan Y; Zhao Q; Chen Z; Swanson BN; Pirozzi G; Mannent L; Graham NMH; Akinlade B; Stahl N; Yancopoulos GD; Radin A
    Gastroenterology; 2020 Jan; 158(1):111-122.e10. PubMed ID: 31593702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis.
    Alexander JA; Jung KW; Arora AS; Enders F; Katzka DA; Kephardt GM; Kita H; Kryzer LA; Romero Y; Smyrk TC; Talley NJ
    Clin Gastroenterol Hepatol; 2012 Jul; 10(7):742-749.e1. PubMed ID: 22475741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin D2 receptor D-type prostanoid receptor 2 mediates eosinophil trafficking into the esophagus.
    Zhang S; Wu X; Yu S
    Dis Esophagus; 2014 Aug; 27(6):601-6. PubMed ID: 24165271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis.
    Rothenberg ME; Wen T; Greenberg A; Alpan O; Enav B; Hirano I; Nadeau K; Kaiser S; Peters T; Perez A; Jones I; Arm JP; Strieter RM; Sabo R; Gunawardena KA
    J Allergy Clin Immunol; 2015 Feb; 135(2):500-7. PubMed ID: 25226850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Montelukast was inefficient in maintaining steroid-induced remission in adult eosinophilic esophagitis.
    Lucendo AJ; De Rezende LC; Jiménez-Contreras S; Yagüe-Compadre JL; González-Cervera J; Mota-Huertas T; Guagnozzi D; Angueira T; González-Castillo S; Arias A
    Dig Dis Sci; 2011 Dec; 56(12):3551-8. PubMed ID: 21674173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma.
    Erpenbeck VJ; Popov TA; Miller D; Weinstein SF; Spector S; Magnusson B; Osuntokun W; Goldsmith P; Weiss M; Beier J
    Pulm Pharmacol Ther; 2016 Aug; 39():54-63. PubMed ID: 27354118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.